Oxford BioDynamics Plc (LON:OBD – Get Free Report) reached a new 52-week low on Monday . The company traded as low as GBX 0.45 ($0.01) and last traded at GBX 0.47 ($0.01), with a volume of 32203789 shares traded. The stock had previously closed at GBX 0.47 ($0.01).
Oxford BioDynamics Trading Up 5.3 %
The firm has a market capitalization of £9.43 million, a PE ratio of -0.09 and a beta of 0.42. The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80. The company has a fifty day moving average of GBX 0.88 and a 200-day moving average of GBX 2.56.
Oxford BioDynamics Company Profile
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Read More
- Five stocks we like better than Oxford BioDynamics
- The How and Why of Investing in Gold Stocks
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Using the MarketBeat Stock Split Calculator
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to Start Investing in Real Estate
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
